SELB Stock Price, News & Analysis

SELB NASDAQ

Company Description

SELB (NASDAQ: SELB) is a publicly traded pharmaceutical preparation manufacturing company in the Manufacturing sector.

SELB stock has declined 45.8% over the past year.

This page provides a comprehensive overview of SELB stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-45.81%

Performance 1 year

$0.0

Market Cap

0.0

Shares outstanding

SELB (SELB) stock. Over the past 12 months, the stock has lost 45.8%.

Latest News

View All

January 8, 2024

+5.87%

Cartesian Therapeutics Highlights Progress and 2024 Strategic Priorities Across Innovative Pipeline of mRNA Cell Therapies for Autoimmunity

January 8, 2024

+5.87%

Cartesian Therapeutics Announces Positive Long-Term Follow-Up Data from Phase 2a Study of Lead mRNA Cell Therapy Candidate Descartes-08 in Patients with Myasthenia Gravis

clinical trial

November 13, 2023

-8.00%

Selecta Biosciences Announces Merger with Cartesian Therapeutics

acquisition

October 31, 2023

-7.20%

Selecta Announces Transition of Manufacturing and Clinical Operations of ImmTOR for SEL-212 to Commercialization Partner Sobi

August 17, 2023

+2.75%

Selecta Biosciences Reports Second Quarter 2023 Financial Results and Updates on Strategic Initiative Designed to Maximize Stockholder Value Associated with SEL-212 Economics

earnings

May 31, 2023

+2.61%

Selecta Biosciences Announces Presentation of Data from Phase 3 DISSOLVE Program of SEL-212 in Chronic Refractory Gout During Late-Breaking Session at the EULAR 2023 European Congress of Rheumatology

clinical trial

SELB has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include clinical trial, acquisition, earnings, conferences, management. View all SELB news →

SEC Filings

View All

No SEC filings available for SELB.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

SELB Company Profile & Sector Positioning

SELB (SELB) operates in the Pharmaceutical Preparation Manufacturing industry within the broader Manufacturing sector and is listed on the NASDAQ.